Naotoshi Sugimoto
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
- Oncology 75
- Colorectal Cancer Treatments and Studies 44
- HER2/EGFR in Cancer Research 12
-
- Gastric Cancer Management and Outcomes 54
- Lung Cancer Treatments and Mutations 21
- Co-authors
- Yoh Takuwa (28 shared papers)Noriko Takuwa (21 shared papers)Sotaro Sakurada (16 shared papers)Hiroyuki Okamoto (5 shared papers)Osamu Shido (40 shared papers)Shuichi Hironaka (19 shared papers)Yoshito Komatsu (18 shared papers)Andrej A. Romanovsky (9 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)Annals of Oncology (12 papers)American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (8 papers)International Journal of Clinical Oncology (5 papers)PLoS ONE (5 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Naotoshi Sugimoto
231 papers receiving 9.2k citations
Naotoshi Sugimoto's Hit Papers
Peers
Comparison fields: 5 of 144
- Gastroenterology 592
- Oncology 2.3k
- Pulmonary and Respiratory Medicine 2.5k
- Cell Biology 1.0k
- Endocrine and Autonomic Systems 371
Countries citing papers authored by Naotoshi Sugimoto
This map shows the geographic impact of Naotoshi Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naotoshi Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naotoshi Sugimoto more than expected).
Fields of papers citing papers by Naotoshi Sugimoto
This network shows the impact of papers produced by Naotoshi Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naotoshi Sugimoto. The network helps show where Naotoshi Sugimoto may publish in the future.
Co-authors
The 25 scholars most cited alongside Naotoshi Sugimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1783 |
| 2 | Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer Hit paper breakdown → | 2020 | 866 |
| 3 | Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils Hit paper breakdown → | 2003 | 569 |
| 4 | Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial Hit paper breakdown → | 2013 | 363 |
| 5 | 2000 | 293 | |
| 6 | 2003 | 267 | |
| 7 | 2012 | 245 | |
| 8 | 2003 | 235 | |
| 9 | 2002 | 198 | |
| 10 | 1996 | 157 | |
| 11 | 2003 | 144 | |
| 12 | 2002 | 141 | |
| 13 | 2001 | 135 | |
| 14 | 2014 | 111 | |
| 15 | 1998 | 105 | |
| 16 | 2005 | 98 | |
| 17 | 1998 | 95 | |
| 18 | 2003 | 94 | |
| 19 | 2022 | 91 | |
| 20 | 2004 | 88 |
About Naotoshi Sugimoto
Naotoshi Sugimoto is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Physiology and Surgery, having authored 243 papers that have together received 9.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (54 papers), Colorectal Cancer Treatments and Studies (44 papers), Lung Cancer Treatments and Mutations (21 papers), Protein Kinase Regulation and GTPase Signaling (16 papers), Thermoregulation and physiological responses (16 papers), Adipose Tissue and Metabolism (14 papers), Sphingolipid Metabolism and Signaling (13 papers) and HER2/EGFR in Cancer Research (12 papers). The work is most often cited by research in Gastroenterology (592 citations), Oncology (2.3k citations), Pulmonary and Respiratory Medicine (2.5k citations), Cell Biology (1.0k citations) and Endocrine and Autonomic Systems (371 citations). Naotoshi Sugimoto has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Yoh Takuwa, Noriko Takuwa, Sotaro Sakurada, Hiroyuki Okamoto, Osamu Shido, Shuichi Hironaka, Yoshito Komatsu, Andrej A. Romanovsky, Kei Muro and Atsushi Ohtsu. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, International Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.